Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.81B |
| 2 |
Microsoft
MSFT
|
+$2.79B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.97B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.28B |
| 5 |
Tesla
TSLA
|
+$1.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$290M |
| 2 |
MRSH
Marsh
MRSH
|
+$136M |
| 3 |
Booking.com
BKNG
|
+$131M |
| 4 |
Starbucks
SBUX
|
+$98.7M |
| 5 |
Baidu
BIDU
|
+$87.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.84% |
| 2 | Healthcare | 15.49% |
| 3 | Consumer Discretionary | 11.17% |
| 4 | Financials | 11.02% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
PubMatic
PUBM
$581M
| $64K | ﹤0.01% |
+3,425
| New | +$61.9K |
|
1502
Aclaris Therapeutics
ACRS
$730M
| $63K | ﹤0.01% |
+3,975
| New | +$62.6K |
|
1503
Plains GP Holdings
PAGP
$5.23B
| $63K | ﹤0.01% |
+5,300
| New | +$60.7K |
|
1504
Perrigo
PRGO
$1.4B
| $63K | ﹤0.01% |
1,778
+107
| +6% | +$4.3K |
|
1505
NETGEAR
NTGR
$669M
| $62K | ﹤0.01% |
+2,849
| New | +$64.1K |
|
1506
Vaxcyte
PCVX
$7.89B
| $62K | ﹤0.01% |
2,604
| – | – |
|
1507
Alkami Technology
ALKT
$1.8B
| $61K | ﹤0.01% |
+3,723
| New | +$54.2K |
|
1508
Crinetics Pharmaceuticals
CRNX
$8.86B
| $61K | ﹤0.01% |
+3,295
| New | +$67.2K |
|
1509
Ares Management
ARES
$28.5B
| $60K | ﹤0.01% |
+883
| New | +$61.7K |
|
|
DCBO
1510
Docebo
DCBO
$492M
| $60K | ﹤0.01% |
2,070
+1,970
| +1,970% | +$60K |
|
1511
International Money Express
IMXI
$392M
| $60K | ﹤0.01% |
+2,473
| New | +$58.1K |
|
1512
Bionano Genomics
BNGO
$12.7M
| $59K | ﹤0.01% |
+45
| New | +$59.5K |
|
1513
Urban Outfitters
URBN
$5.99B
| $59K | ﹤0.01% |
+2,695
| New | +$56.5K |
|
1514
Xometry
XMTR
$4.77B
| $59K | ﹤0.01% |
+944
| New | +$44.1K |
|
1515
LeMaitre Vascular
LMAT
$2.18B
| $58K | ﹤0.01% |
1,151
+59
| +5% | +$2.95K |
|
1516
Maximus
MMS
$3.14B
| $58K | ﹤0.01% |
996
| – | – |
|
|
RDFN
1517
DELISTED
Redfin
RDFN
| $58K | ﹤0.01% |
9,872
| – | – |
|
1518
Arvinas
ARVN
$518M
| $57K | ﹤0.01% |
1,262
| – | – |
|
1519
Magnite
MGNI
$2.65B
| $57K | ﹤0.01% |
7,490
| – | – |
|
|
SGMO
1520
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $57K | ﹤0.01% |
+11,484
| New | +$59K |
|
1521
Advantage Solutions
ADV
$484M
| $56K | ﹤0.01% |
945
| – | – |
|
|
EB
1522
DELISTED
Eventbrite
EB
| $56K | ﹤0.01% |
+8,592
| New | +$72.4K |
|
1523
JetBlue
JBLU
$1.96B
| $55K | ﹤0.01% |
7,650
| – | – |
|
1524
Nektar Therapeutics
NKTR
$2.39B
| $55K | ﹤0.01% |
+1,090
| New | +$64.8K |
|
1525
Invesco Leisure and Entertainment ETF
PEJ
$252M
| $55K | ﹤0.01% |
1,502
-95,032
| -98% | -$3.68M |
|
Similar funds
Amundi's Q3 2022 Portfolio in Review
As of Q3 2022, Amundi held 1,927 positions worth $169B, up 35% from $125B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Amundi deployed $45.4B of net new capital in Q3 2022, opening 247 new positions and adding to 905 existing holdings. Its largest new stake was Graco: 1,213,227 shares worth $76.8M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was SLB Ltd, an estimated $290M trimmed.
- Amundi's largest Q3 2022 buy was Graco: 1,213,227 shares worth $76.8M.
- Amundi added most to Apple in Q3 2022, an estimated $2.81B increase.
- Amundi's biggest Q3 2022 reduction was SLB Ltd, cutting an estimated $290M.
- Amundi fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2022, selling an estimated $81.5M.
- Amundi's ten largest holdings make up 19% of its $169B portfolio in Q3 2022.
- Amundi opened 247 new positions and closed 85 in Q3 2022.
- Amundi's portfolio value rose 35% quarter-over-quarter to $169B.
Based on Amundi's 13F filing for Q3 2022, filed 14 Nov 2022.